According to the latest data from the Hong Kong Stock Exchange, on July 22, E Fund Management increased its holding in Shandong Xinhua Pharmaceutical (00719) by 198,000 shares.
The transaction was executed at a price of HK$6.2566 per share, with a total value of approximately HK$1.2388 million.
Following this increase, the fund's latest shareholding count stands at 13.798 million shares, representing a latest shareholding ratio of 7.08%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments